A candida auris outbreak and its control in an intensive care setting

New England Journal of Medicine

Volumn 379, Issue 14, 2018, Pages 1322-1331

  Eyre, David W ^a,b,c   Sheppard, Anna E ^b,c   Madder, Hilary ^a   Moir, Ian ^a   Moroney, Ruth ^a   Quan, T Phuong ^b,c   Griffiths, David ^b   George, Sophie ^b   Butcher, Lisa ^a   Morgan, Marcus ^a   Newnham, Robert ^a   Sunderland, Mary ^a   Clarke, Tiphanie ^a   Foster, Dona ^b   Hoffman, Peter ^d   Borman, Andrew M ^e   Johnson, Elizabeth M ^e   Moore, Ginny ^d   Brown, Colin S ^d   Walker, A Sarah ^b,c   Peto, Tim E A ^a,b,c   Crook, Derrick W ^a,b,c,d   Jeffery, Katie J M ^a   more..

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; SODIUM;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; AXILLA TEMPERATURE; BODY TEMPERATURE; CANDIDA ALBICANS; CANDIDA AURIS; CANDIDA AURIS INFECTION; EPIDEMIC; FUNGAL COLONIZATION; FUNGAL DETECTION; FUNGAL GENOME; FUNGUS ISOLATION; GENOTYPE; HUMAN; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MYCOSIS; NEUTROPHIL COUNT; NONHUMAN; PATIENT MONITORING; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; SKIN SURFACE; SKIN TEMPERATURE; SODIUM BLOOD LEVEL; UNITED KINGDOM; WHOLE GENOME SEQUENCING; CANDIDA; CANDIDIASIS; CASE CONTROL STUDY; CROSS INFECTION; FEMALE; GENETICS; HOSPITAL DEPARTMENT; INCIDENCE; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MALE; MEDICAL DEVICE CONTAMINATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEUROLOGY; PHYLOGENY; PROCEDURES; RECYCLING; THERMOMETER; TRANSMISSION;

ADULT; CANDIDA; CANDIDIASIS; CASE-CONTROL STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; EQUIPMENT CONTAMINATION; EQUIPMENT REUSE; FEMALE; HOSPITAL DEPARTMENTS; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROLOGY; PHYLOGENY; RISK FACTORS; THERMOMETERS; UNITED KINGDOM;

EID: 85054433118     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1714373     Document Type: Article

References (21)

1. Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog 2017; 13(5): e1006290.
2. Chowdhary A, Voss A, Meis JF. Multidrug- resistant Candida auris: 'new kid on the block' in hospital-associated infections? J Hosp Infect 2016; 94: 209-12.
3. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 2009; 53: 41-4.
4. Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 2011; 49: 3139-42.
5. Lockhart SR, Etienne KA, Vallabhaneni S, et al. Simultaneous emergence of multidrug- resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 2017; 64: 134-40.
6. Borman AM, Szekely A, Johnson EM. Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. Med Mycol 2017; 55: 563-7.
7. Ruiz Gaitán AC, Moret A, López Hontangas JL, et al. Nosocomial fungemia by Candida auris: first four reported cases in continental Europe. Rev Iberoam Micol 2017; 34: 23-7.
8. Candida auris in healthcare settings - Europe. Solna, Sweden: European Centre for Disease Prevention and Control, December 19, 2016 (https://ecdc .europa .eu/ sites/ portal/ files/ media/ en/ publications/ Publications/ Candida -in -healthcare -settings- 19 -Dec -2016 .pdf).
9. Larkin E, Hager C, Chandra J, et al. The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on growth morphology and biofilm formation. Antimicrob Agents Chemother 2017; 61(5): e02396-e16.
10. Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 2016; 5: 35.
11. Rhodes J, Abdolrasouli A, Farrer RA, et al. Rapid genome sequencing for outbreak analysis of the emerging human fungal pathogen Candida auris. bioRxiv. October 13, 2017 (https://www .biorxiv .org/ content/ biorxiv/ early/ 2017/ 10/ 13/ 201343 .full .pdf).
12. Clinical alert to U.S. healthcare facilities: global emergence of invasive infections caused by the multidrug-resistant yeast Candida auris. Atlanta: Centers for Disease Control and Prevention, June 2016 (https://www .cdc .gov/ fungal/ diseases/ candidiasis/ candida -auris -alert .html).
13. Guidance for the laboratory investigation, management and infection prevention and control for cases of Candida auris. London: Public Health England, August 2017 (https://www .gov .uk/ government/ uploads/ system/ uploads/ attachment-data/ file/ 637685/ Updated-Candida-auris -Guidance-v2 .pdf).
14. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 2012; 29: 1969-73.
15. Eyre DW, Cule ML, Griffiths D, et al. Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission. PLoS Comput Biol 2013; 9(5): e1003059.
16. Sharma C, Kumar N, Meis JF, Pandey R, Chowdhary A. Draft genome sequence of a fluconazole-resistant Candida auris strain from a candidemia patient in India. Genome Announc 2015; 3(4): e00722-15.
17. Cadnum JL, Shaikh AA, Piedrahita CT, et al. Effectiveness of disinfectants against Candida auris and other candida species. Infect Control Hosp Epidemiol 2017; 38: 1240-3.
18. Rudramurthy SM, Chakrabarti A, Paul RA, et al. Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother 2017; 72: 1794- 801.
19. Welsh RM, Bentz ML, Shams A, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol 2017; 55: 2996- 3005.
20. Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ. Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and other candida species. Infect Control Hosp Epidemiol 2017; 38: 1107-9.
21. Vallabhaneni S, Kallen A, Tsay S, et al. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep 2016; 65: 1234-7.